Short interest screen · refreshed after the Nov 9, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 51 | KMTSKestra Medical TechnologiesHealthcare | $29.43 | +2.17% | 12.3 | 12.9% | +5% | $1.75B |
| 52 | CORTCorcept TherapeuticsHealthcare | $74.95 | +3.00% | 12.3 | 9.0% | +1% | $8.10B |
| 53 | SVRASavaraHealthcare | $4.99 | +3.31% | 12.2 | 20.1% | −34% | $1.03B |
| 54 | OMEROmerosHealthcare | $17.58 | +3.90% | 12.2 | 17.8% | 0% | $1.27B |
| 55 | IMNMImmunomeHealthcare | $19.48 | +4.12% | 12.2 | 17.1% | +3% | $2.30B |
| 56 | LBRXLB PharmaceuticalsHealthcare | $45.18 | +7.53% | 12.1 | 23.0% | −7% | $1.46B |
| 57 | IDYAIDEAYA BiosciencesHealthcare | $31.90 | +2.11% | 12.0 | 10.4% | −1% | $3.08B |
| 58 | PTGXProtagonist TherapeuticsHealthcare | $135.57 | +2.67% | 12.0 | 16.8% | +10% | $8.77B |
| 59 | FDMT4D Molecular TherapeuticsHealthcare | $12.37 | +0.98% | 12.0 | 21.6% | +3% | $683.4M |
| 60 | DSGNDesign TherapeuticsHealthcare | $10.69 | +4.70% | 12.0 | 21.8% | +1% | $684.5M |
| 61 | SLSSELLAS Life Sciences GroupHealthcare | $8.69 | +3.21% | 12.0 | 27.0% | −2% | $1.75B |
| 62 | LENZLENZ TherapeuticsHealthcare | $4.17 | +18.32% | 11.8 | 46.7% | −14% | $130.9M |
| 63 | RAPPRapport TherapeuticsHealthcare | $25.28 | +3.44% | 11.8 | 10.9% | −4% | $1.50B |
| 64 | BRVEBraveheart BioHealthcare | $19.35 | +4.03% | 11.8 | 10.9% | +19% | $1.74B |
| 65 | RNACCartesian TherapeuticsHealthcare | $7.39 | −1.86% | 11.7 | 15.6% | +1% | $225.4M |
| 66 | EIKNEikon TherapeuticsHealthcare | $5.74 | −2.71% | 11.7 | 20.4% | +1% | $310.9M |
| 67 | TSHATaysha Gene TherapiesHealthcare | $4.40 | +1.62% | 11.6 | 17.6% | −7% | $1.43B |
| 68 | BCAXBicara TherapeuticsHealthcare | $9.97 | +15.26% | 11.5 | 23.9% | −4% | $659.7M |
| 69 | PRLDPrelude Therapeutics IncorporatedHealthcare | $3.82 | +6.11% | 11.5 | 13.2% | +11% | $304.8M |
| 70 | EXELExelixisHealthcare | $71.85 | +3.28% | 11.3 | 11.4% | −3% | $17.53B |
| 71 | CYHCommunity Health SystemsHealthcare | $2.28 | +2.94% | 11.3 | 10.4% | 0% | $320.8M |
| 72 | AKTSAktis OncologyHealthcare | $16.18 | +2.24% | 11.3 | 18.3% | −9% | $899.6M |
| 73 | GLUEMonte Rosa TherapeuticsHealthcare | $10.51 | −0.57% | 11.2 | 41.9% | +5% | $898.1M |
| 74 | HROWHarrowHealthcare | $27.38 | +1.82% | 11.2 | 24.3% | −4% | $1.03B |
| 75 | TNGXTango TherapeuticsHealthcare | $22.73 | +5.72% | 11.2 | 31.9% | +1% | $3.83B |
| 76 | DMRADamora TherapeuticsHealthcare | $24.62 | +3.88% | 11.2 | 11.2% | +9% | $1.52B |
| 77 | ASMBAssembly BiosciencesHealthcare | $21.04 | +3.04% | 11.1 | 28.0% | +3% | $428.4M |
| 78 | SANASana BiotechnologyHealthcare | $2.36 | −0.63% | 11.0 | 22.2% | +5% | $705.6M |
| 79 | JBIOJade BiosciencesHealthcare | $16.02 | +6.27% | 10.9 | 20.7% | −7% | $1.02B |
| 80 | GLSIGreenwich LifeSciencesHealthcare | $16.92 | +11.54% | 10.7 | 24.5% | −2% | $248.4M |
| 81 | AVIRAtea PharmaceuticalsHealthcare | $4.41 | +2.32% | 10.7 | 5.0% | −61% | $353.7M |
| 82 | NAMSNewAmsterdam Pharma Company N.VHealthcare | $18.22 | −3.60% | 10.6 | 16.4% | −26% | $2.19B |
| 83 | AURAAura BiosciencesHealthcare | $7.47 | +13.87% | 10.6 | 11.8% | +5% | $774.7M |
| 84 | IRONDisc MedicineHealthcare | $80.33 | +1.80% | 10.6 | 22.8% | +3% | $3.66B |
| 85 | ANABAnaptysBioHealthcare | $47.59 | +2.45% | 10.6 | 30.6% | +3% | $1.42B |
| 86 | TECXTectonic TherapeuticHealthcare | $21.71 | +5.16% | 10.6 | 19.1% | 0% | $424.3M |
| 87 | LIVNLivaNovaHealthcare | $92.39 | +2.66% | 10.6 | 11.3% | +3% | $5.09B |
| 88 | LGNDLigand PharmaceuticalsHealthcare | $312.48 | +2.06% | 10.5 | 13.3% | −7% | $6.25B |
| 89 | ORICOric PharmaceuticalsHealthcare | $9.22 | +4.54% | 10.5 | 25.5% | −5% | $955.7M |
| 90 | KYTXKyverna TherapeuticsHealthcare | $5.16 | +5.74% | 10.5 | 26.6% | −1% | $319.1M |
| 91 | ALTAltimmuneHealthcare | $2.14 | +2.88% | 10.4 | 22.2% | −8% | $416.3M |
| 92 | ORMPOramed PharmaceuticalsHealthcare | $3.95 | +2.33% | 10.4 | 4.3% | +1% | $164.3M |
| 93 | INVAInnovivaHealthcare | $19.14 | +0.21% | 10.4 | 10.5% | +6% | $1.36B |
| 94 | CLYMClimb BioHealthcare | $11.10 | +7.87% | 10.3 | 25.6% | +1% | $652.0M |
| 95 | SGRYSurgery PartnersHealthcare | $26.20 | +12.93% | 10.3 | 18.3% | 0% | $3.38B |
| 96 | KRYSKrystal BiotechHealthcare | $302.57 | +0.56% | 10.3 | 12.9% | −16% | $8.97B |
| 97 | ANNXAnnexonHealthcare | $4.29 | +2.02% | 10.3 | 20.6% | −1% | $812.3M |
| 98 | ELDNEledon PharmaceuticalsHealthcare | $2.83 | +8.64% | 10.3 | 9.7% | +1% | $230.0M |
| 99 | CRSPCRISPR Therapeutics AGHealthcare | $50.59 | +1.04% | 10.2 | 21.0% | −12% | $4.91B |
| 100 | PGENPrecigenHealthcare | $4.82 | +7.83% | 10.2 | 26.1% | −2% | $1.73B |
Data guard: 1 stock withheld — KPLT (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.